In 2023, Germany's import of pacemakers for stimulating heart muscles stood at a certain level. The forecast data from 2024 to 2028 suggests a gradual decline in import values, with an observed decrease from $428.28 million in 2024 to $423.71 million by 2028. This indicates a consistent year-on-year negative trend in import values. The average Compound Annual Growth Rate (CAGR) over this period illustrates a diminishing market demand or sourcing shift.

Future trends to watch for:

The impact of technological advancements improving pacemaker efficiency and longevity.
Potential policy changes affecting medical device imports in Germany.
Emerging domestic competitors or suppliers leading to reduced dependency on imports.